PRECeDe: Prevention of neonatal Respiratory morbidity with antenatal corticosteroids prior to Elective Caesarean section in women with Diabetes: A Randomised trial

  • Said, Joanne (Primary Chief Investigator (PCI))
  • Groom, Katie (Chief Investigator (CI))
  • Crowther, Caroline Anne (Chief Investigator (CI))
  • Doyle, Lex William (Chief Investigator (CI))
  • Karahalios, Amalia (Chief Investigator (CI))
  • Mol, Ben (Chief Investigator (CI))
  • Harding, Jane E (Chief Investigator (CI))
  • Yates, Christopher J (Chief Investigator (CI))
  • Henry, Amanda G (Chief Investigator (CI))
  • Whitehead, Clare (Chief Investigator (CI))

Project: Research

Project Details

Project Description

Given the rising rates of both diabetes in pregnancy and elective CS, there is an urgent need to provide the strongest level of evidence regarding the balance of benefits and risks of antenatal corticosteroids for women with diabetes, and their babies, born by elective CS. The PRECeDe trial is designed to provide this evidence.
Short titlePRECeDE
StatusActive
Effective start/end date1/07/23 → 30/06/27